Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/42157
Title: CYP2C19 or CYP3A5 genotyping do not predict clinical response to clopidogrel
Authors: Rodríguez-González, F.
Martínez Quintana, Efrén 
Saavedra Santana, Pedro 
Medina-Gil, J. M.
Riano, M.
Garay-Sánchez, P.
Tugores, A. 
UNESCO Clasification: 32 Ciencias médicas
Keywords: Aspirin
Clopidogrel
CYP2C19
CYP3A5
Diabetes
Calcium channel blockers
Issue Date: 2018
Publisher: 1742-7835
Journal: Basic and Clinical Pharmacology and Toxicology 
URI: http://hdl.handle.net/10553/42157
ISSN: 1742-7835
Source: Basic and Clinical Pharmacology and Toxicology [ISSN 1742-7835], v. 123 (S2), p. 32
Appears in Collections:Actas de congresos
Show full item record

Page view(s)

17
checked on Feb 21, 2021

Google ScholarTM

Check


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.